- Home
- EWCZ vs STXS Comparison
EWCZ vs STXS Comparison
Compare EWCZ & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- STXS
- Stock Information
- Founded
- EWCZ 2004
- STXS 1990
- Country
- EWCZ United States
- STXS United States
- Employees
- EWCZ N/A
- STXS N/A
- Industry
- EWCZ Package Goods/Cosmetics
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EWCZ Consumer Discretionary
- STXS Health Care
- Exchange
- EWCZ Nasdaq
- STXS Nasdaq
- Market Cap
- EWCZ 146.9M
- STXS 151.3M
- IPO Year
- EWCZ 2021
- STXS 2004
- Fundamental
- Price
- EWCZ $3.57
- STXS $2.14
- Analyst Decision
- EWCZ Buy
- STXS
- Analyst Count
- EWCZ 7
- STXS 0
- Target Price
- EWCZ $5.64
- STXS N/A
- AVG Volume (30 Days)
- EWCZ 773.2K
- STXS 285.8K
- Earning Date
- EWCZ 05-14-2025
- STXS 05-12-2025
- Dividend Yield
- EWCZ N/A
- STXS N/A
- EPS Growth
- EWCZ 29.60
- STXS N/A
- EPS
- EWCZ 0.22
- STXS N/A
- Revenue
- EWCZ $216,916,000.00
- STXS $26,918,000.00
- Revenue This Year
- EWCZ N/A
- STXS $25.90
- Revenue Next Year
- EWCZ $2.69
- STXS $60.57
- P/E Ratio
- EWCZ $16.18
- STXS N/A
- Revenue Growth
- EWCZ N/A
- STXS 0.55
- 52 Week Low
- EWCZ $2.72
- STXS $1.54
- 52 Week High
- EWCZ $12.05
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- EWCZ 50.91
- STXS 63.79
- Support Level
- EWCZ $3.12
- STXS $1.93
- Resistance Level
- EWCZ $3.42
- STXS $2.07
- Average True Range (ATR)
- EWCZ 0.21
- STXS 0.09
- MACD
- EWCZ 0.11
- STXS 0.02
- Stochastic Oscillator
- EWCZ 85.52
- STXS 75.79
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.